Larazotide acetate (also recognized as AT-1001) is a novel, synthetic, eight-amino acid peptide.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Larazotide acetate;881851-50-9;AT-1001;Larazotide (acetate);UNII-FO8S2IW40N;Larazotide acetate [USAN];Larazotide acetate (USAN);FO8S2IW40N;acetic acid;2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid;AT-1001 (LARAZOTIDE ACETATE);Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine acetate;Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate;AT1001;Larazotide Acetate?;Zot protein, Vibrio cholerae (288-293);CHEMBL2103815;NYGCNONRVCGHAT-UFIKZEAMSA-N;DTXSID401007986;LARAZOTIDE ACETATE [WHO-DD];AKOS040741936;CS-8047;HY-106268A;BS-44707;DA-74889;FL177565;D09352;F77451;Q25327025;Acetic acid--N-[(1-{N-[14-amino-1,4,7,10,13-pentahydroxy-5-(2-methylpropyl)-2,8-di(propan-2-yl)-3,6,9,12-tetraazatetradeca-3,6,9,12-tetraen-1-ylidene]-5-hydroxy-5-iminonorvalyl}pyrrolidin-2-yl)(hydroxy)methylidene]glycine (1/1); |
M.F/Formula | C34H59N9O12 |
M.W/Mr. | 785.9 |
Sequence | One Letter Code:GGVLVQPG Three Letter Code:H-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH.CH3CO2H |
Appearance | White Solid |
Biological Activity | AT-1001, also known as Larazotide Acetate, is a tight junction regulator and reverses leaky junctions to their normally closed state. It is being studied in people with celiac disease. |
Long-term Storage Conditions | Water (Slightly) |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1 |
InChI Key | NYGCNONRVCGHAT-UFIKZEAMSA-N |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com